AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® for the Treatment of Adults with Active Psoriatic Arthritis – Press Release

NewsReport March 17, 2022

0 Less than a minute

[ad_1]

Home
US
,
Press Releases
,
Company Announcements
AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® for the Treatment of Adults with Active Psoriatic Arthritis – InvestingNews.com

US
Press Releases
Company Announcements
Investing News

Thursday, March 17, 2022 12:24 EST
0 mins read

Source: NewsService

NewsReport March 17, 2022

0 Less than a minute